Picture of Hikma Pharmaceuticals logo

HIK Hikma Pharmaceuticals News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

REG - Hikma Pharmaceutical - Change of Hikma interim dividend payment date

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220914:nRSN4261Za&default-theme=true

RNS Number : 4261Z  Hikma Pharmaceuticals Plc  14 September 2022

Payment of Hikma interim dividend moved to 20 September 2022

 

 

London, 14 September 2022 - Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK)
(Hikma) announces that the payment of its interim dividend, originally
scheduled for Monday 19 September 2022, will now be paid on Tuesday 20
September 2022.

 

This change follows the announcement of a bank holiday on Monday 19 September
2022, made by the UK Government on Saturday 10 September 2022, for Her Majesty
Queen Elizabeth II's State Funeral and the subsequent releases made by the
Bank of England and Euroclear UK & International that in line with their
usual bank holiday processes, their systems, required to settle this dividend
payment, will be closed on this bank holiday.

 

 

-- ENDS --

 

Enquiries:

 

Hikma Pharmaceuticals PLC

Hussein Arkhagha, Chief Counsel and Company Secretary
                   +44 (0)20 7399 2760

Susan Ringdal, EVP Strategic Planning and Global Affairs
                        +44 (0)20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVVZLBFLKLFBBD

Recent news on Hikma Pharmaceuticals

See all news